Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0Q77

Ab Science (0Q77)

Ab Science Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q77
DateTimeSourceHeadlineSymbolCompany
03/13/20247:58AMUK RegulatoryAB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmuneLSE:0Q77Ab Science Sa
03/13/20247:58AMUK RegulatoryAB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative diseaseLSE:0Q77Ab Science Sa
03/07/20249:20AMUK RegulatoryAB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science developmentLSE:0Q77Ab Science Sa
03/07/20249:20AMUK RegulatoryAB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB ScienceLSE:0Q77Ab Science Sa
03/06/20242:21PMUK RegulatoryAB Science annonce l’initiation de la couverture de son titre par deux sociétés d’analyse financières, DNA Finance d’une part, et par In Extenso Finance d’autre partLSE:0Q77Ab Science Sa
03/06/20242:21PMUK RegulatoryAB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the CompanyLSE:0Q77Ab Science Sa
03/01/202412:07PMUK RegulatoryAB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30LSE:0Q77Ab Science Sa
03/01/202412:07PMUK RegulatoryAB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CETLSE:0Q77Ab Science Sa
02/29/20245:49AMUK RegulatoryAB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CETLSE:0Q77Ab Science Sa
02/29/20245:49AMUK RegulatoryAB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30LSE:0Q77Ab Science Sa
02/26/202412:32PMUK RegulatoryAB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALSLSE:0Q77Ab Science Sa
02/26/202412:32PMUK RegulatoryAB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLALSE:0Q77Ab Science Sa
01/26/202412:01PMUK RegulatoryAB Science fait le point sur la demande d’autorisation de mise sur le marché du masitinib dans la sclérose latérale amyotrophique auprès de l’Agence Européenne des MédicamentsLSE:0Q77Ab Science Sa
01/26/202412:01PMUK RegulatoryAB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines AgencyLSE:0Q77Ab Science Sa
 Showing the most relevant articles for your search:LSE:0Q77